BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24650289)

  • 41. New knowledge of genetic pathogenesis of hemochromatosis and Wilson's disease.
    Bacon BR; Schilsky ML
    Adv Intern Med; 1999; 44():91-116. PubMed ID: 9929706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
    Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
    Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Determination of copper in hepatic tissue for the diagnosis of Wilson's disease].
    Bataller Sifre R; Peydro Olaya A; Arroyo Vicente M; Bataller Alberola RM; Carda Batalla C; Broseta Aguado R
    An Med Interna; 1989 Mar; 6(3):145-8. PubMed ID: 2491190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Wilson disease: genetic basis of copper toxicity and natural history.
    Schilsky ML
    Semin Liver Dis; 1996 Feb; 16(1):83-95. PubMed ID: 8723326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology and treatment of Wilson's disease.
    Tankanow RM
    Clin Pharm; 1991 Nov; 10(11):839-49. PubMed ID: 1794220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wilson Disease.
    Pfeiffer RF
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1246-61. PubMed ID: 27495207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [From gene to disease; Wilson disease: copper storage due to mutations in ATP7B].
    Stapelbroek JM; Ploos van Amstel JK; van Hattum J; van den Berg LH; Klomp LW; Houwen RH
    Ned Tijdschr Geneeskd; 2003 Mar; 147(13):603-5. PubMed ID: 12701394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Haemolytic anaemia as a first sign of Wilson's disease.
    Balkema S; Hamaker ME; Visser HP; Heine GD; Beuers U
    Neth J Med; 2008 Sep; 66(8):344-7. PubMed ID: 18809982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three atypical cases of Wilson disease: assessment of the Leipzig scoring system in making a diagnosis.
    Xuan A; Bookman I; Cox DW; Heathcote J
    J Hepatol; 2007 Sep; 47(3):428-33. PubMed ID: 17629589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The hepatic form of Wilson's disease in young patients].
    Smolka V; Frysák Z; Kozák L; Mathonová J; Jezdinská V; Novák Z; Hrcková Y; Vrábelová S
    Vnitr Lek; 2000 Jan; 46(1):24-9. PubMed ID: 10953660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnosis and care of Wilson disease with neurological revelation].
    Wagner S; Brunet AS; Bost M; Lachaux A; Broussolle E; Des Portes V; Lion-François L
    Arch Pediatr; 2012 Mar; 19(3):271-6. PubMed ID: 22261259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pitfalls of diagnosis in the early stages of Wilson's disease.
    Crumley FE
    J Am Acad Child Adolesc Psychiatry; 1990 May; 29(3):470-1. PubMed ID: 2347848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kayser-Fleischer-like rings in patients without Wilson's disease.
    Frommer D; Morris J; Sherlock S; Abrams J; Newman S
    Gastroenterology; 1977 Jun; 72(6):1331-5. PubMed ID: 558126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic features of Wilson disease.
    Boga S; Ala A; Schilsky ML
    Handb Clin Neurol; 2017; 142():91-99. PubMed ID: 28433114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease.
    LaRusso NF; Summerskill WH; McCall JT
    Gastroenterology; 1976 May; 70(5 PT.1):653-5. PubMed ID: 1261757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Clinical Utility of a Low Serum Ceruloplasmin Measurement in the Diagnosis of Wilson Disease.
    Kelly D; Crotty G; O'Mullane J; Stapleton M; Sweeney B; O'Sullivan SS
    Ir Med J; 2016 Jan; 109(1):341-3. PubMed ID: 26904791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wilson disease: what is still unclear in pediatric patients?
    Ranucci G; Socha P; Iorio R
    Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):268-72. PubMed ID: 24745882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Four-year follow-up of a Wilson disease pedigree complicated with epilepsy and hypopituitarism: Case report with a literature review.
    Zhang QJ; Xu LQ; Wang C; Hu W; Wang N; Chen WJ
    Medicine (Baltimore); 2016 Dec; 95(49):e5331. PubMed ID: 27930511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metallothionein: a game changer in histopathological diagnosis of Wilson disease.
    Wiethoff H; Mohr I; Fichtner A; Merle U; Schirmacher P; Weiss KH; Longerich T
    Histopathology; 2023 Dec; 83(6):936-948. PubMed ID: 37661783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wilson Disease: An Overview and Approach to Management.
    Mulligan C; Bronstein JM
    Neurol Clin; 2020 May; 38(2):417-432. PubMed ID: 32279718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.